Marshall Wace North America’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-215
Closed -$204K 1681
2018
Q4
$204K Buy
+215
New +$204K ﹤0.01% 953